Boston Scientific's endoscopy, urology and pelvic health divisions are propelling the company's growth, Seeking Alpha reports.
Here are four insights into the endoscopy division:
1. Boston Scientific is estimated to hold 30 percent of the global endoscopy market. Its market share is valued at $5 billion.
2. Seeking Alpha reports the company's endoscopy-related sales occur at a greater rate than the rest of the market, "which implies that the company is witnessing steady rise of market share."
3. Boston Scientific anticipates reporting $2 billion in endoscopy-related revenues by 2020, while the market itself is anticipated to swell to $7 billion by 2021. If the market does expand to that level, it could offer a greater market share.
4. SeekingAlpha pointed to the company's acquisitions of EndoChoice Holdings and EmCision as doubling down on the endoscopy market's potential. Since acquiring EndoChoice in November 2016, Boston Scientific expanded its current market offerings through the addition of two new divisions.